Screener
Janux Therapeutics JANX Price / sales
Price / sales at other companies
Other financials
Where this comes from
Calculated from Janux Therapeutics’s reported figures.
Based on the most recent quarter.
The source filing: Janux Therapeutics’s 10-Q, filed August 6, 2026. Open the filing →
- Filed
- Aug 6, 2026, 4:18 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-338078
FAQ
- What is Janux Therapeutics's price / sales?
- Janux Therapeutics (JANX) reported price / sales of 39× in Q2 2026.
- How has Janux Therapeutics's price / sales changed year-over-year?
- Janux Therapeutics's price / sales decreased by 98.8% year-over-year, from 3,147.5× to 39×.
- What is the long-term trend for Janux Therapeutics's price / sales?
- Over 4 years (2021 to 2025), Janux Therapeutics's price / sales has grown at a -22.0% compound annual growth rate (CAGR), from 224.1× to 83×.
- What does price / sales mean?
- Market capitalization at the quarter end divided by trailing-twelve-month revenue. The price the market pays for each dollar of sales.
Ask your AI about Janux Therapeutics's price / sales.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude